Zhou Zhou
Chengdu, 610000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Correlation of Omentin-1 with Disease Extent and Therapeutic Response to Infliximab in Ulcerative Colitis.
Journal: Journal of inflammation research
Published: January 15, 2026
Beyond inflammation: what drives the self-perpetuating cycle of fibrosis in IBD?
Journal: Annals of medicine
Published: November 05, 2025
Kurarinone ameliorates intestinal mucosal inflammation via regulating T cell immunity.
Journal: Frontiers in immunology
Published: March 04, 2025
Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome.
Journal: Journal of inflammation research
Published: October 07, 2024
The Effect of Drugs on the Intestinal Microbiota in Crohn's Disease.
Journal: Biomedicines
Published: August 25, 2024
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn's Disease.
Journal: Journal of inflammation research
Published: May 29, 2024
The Neutrophil-to-Albumin Ratio (NAR): A Novel Index in Relation to Clinical Symptoms, Quality of Life, and Psychological Status in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D).
Journal: Journal of inflammation research
Published: January 06, 2024
Association between serum omentin-1 and mucosal disease activity in patients with ulcerative colitis.
Journal: Postgraduate medical journal
Published: June 15, 2023
Clinical significance of the C-reactive protein-to-bilirubin ratio in patients with ulcerative colitis.
Journal: Frontiers in medicine
Published: May 24, 2023
Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis.
Journal: Journal of inflammation research
Published: April 05, 2023
Clinical significance of a novel uric-acid-based biomarker in the prediction of disease activity and response to infliximab therapy in Crohn's disease.
Journal: Scandinavian journal of gastroenterology
Published: February 25, 2023
Last Updated: 09/26/2026